% Expired Patents = 83.3

EPO Patents = 3

Trademarks = 1

Forward Citations = 8

Loading Chart...

1 inventor (with patents filed for the assignee):

Paul T Mann (6 out of 10 patents)

6 patents: Sort by Forward Citations

1. 9370552 - Protein A compositions and methods of use (2016-06-21),

2. 8603486 - Protein A compositions and methods of use (2013-12-10),

3. 8168189 - Protein A compositions and methods of use (2012-05-01),

4. 7807170 - Protein A compositions and methods of use (2010-10-05),

5. 7425331 - Protein A methods of use (2008-09-16),

6. 7211258 - Protein A compositions and methods of use (2007-05-01),

Protalex, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel therapies for the treatment of autoimmune and inflammatory diseases. Their lead product candidate, PRTX-100, is aimed at addressing unmet medical needs in diseases such as rheumatoid arthritis and immune thrombocytopenia. Protalex is dedicated to advancing innovative treatments that improve the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

6 Patents

#10 in Summit, NJ

#1,670 in New Jersey

#44,869 in US

Summit, NJ, United States of America

Protalex, Inc.

Forward Citations = 8

1 inventor:

Paul T Mann (6 out of 10 patents)

Please report any incorrect information to [email protected]

3 patents (EPO):

Please report any incorrect information to [email protected]